日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer

自动化成像技术作为血清和临床生物标志物的辅助手段:一种用于转移性去势抵抗性前列腺癌的新型验证预测工具

Morris, Michael J; Flynn, Jessica; Zhao, Binsheng; Anand, Aseem; Sjöstrand, Karl; Larson, Steven M; Regazzi, Ashley M; Borzillo, Gary V; Park, Autumn; Schwartz, Lawrence H; Heller, Glenn

Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma

采用对流增强递送方式的放射免疫治疗诊断药物 124I-Omburtamab 治疗弥漫性内生性脑桥胶质瘤的 1 期剂量递增试验

Souweidane, Mark M; Bander, Evan D; Zanzonico, Pat; Reiner, Anne S; Manino, Nicole; Haque, Sofia; Carrasquillo, Jorge A; Lyashchenko, Serge K; Thakur, Sunitha B; Lewis, Jason S; Donzelli, Maria; Cheung, Nai-Kong V; Larson, Steven M; Kramer, Kim; Pandit-Taskar, Neeta; Dunkel, Ira J

GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer

在转移性人结直肠癌小鼠原位肝脏异种移植模型中,采用基于单价和二价DOTA的Lu-177标记放射性半抗原进行GPA33预靶向放射免疫治疗

Le Roux, Alexandre B; Fung, Edward K; Lee, Sang Gyu; Monette, Sebastien; Xu, Hong; Guo, Hong-Fen; Yang, Guangbin; Ouerfelli, Ouathek; Jungbluth, Achim; Schöder, Heiko; Larson, Steven M; Cheung, Nai-Kong V; Cheal, Sarah M; Veach, Darren R

Comparison of targeting two antigens (GPA33 versus HER2) for (225)Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer

比较靶向两种抗原(GPA33 与 HER2)的(225)Ac 预靶向 α 放射免疫疗法治疗结直肠癌

Rinne, Sara S; Vargas, Daniela Burnes; Vaughn, Brett A; Katugampola, Sumudu; Miller, Brian W; Veach, Darren R; Punzalan, Blesida; de Stanchina, Elisa; Yaeger, Rona; Miranda, Ileana C; Xu, Hong; Guo, Hongfen; Schwartz, Jazmin; Fung, Edward K; Howell, Roger W; Larson, Steven M; Cheung, Nai-Kong V; Cheal, Sarah M

Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translation

腹膜癌放射免疫疗法:从临床前概念验证到临床转化

Aguirre, Nicole; Veach, Darren R; Cercek, Andrea; Cheal, Sarah M; Larson, Steven M; Nash, Garrett M; Cheung, Nai-Kong V

Microstructural Assessment of Molybdenum Disulfide Coatings Using Nanoindentation Hardness

利用纳米压痕硬度法对二硫化钼涂层的微观结构进行评估

Babuska, Tomas F; Mings, Alexander; Larson, Steven R; Dugger, Michael T; Rodriguez, Mark A; Curry, John F

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

2025年美国甲状腺协会成人分化型甲状腺癌管理指南

Ringel, Matthew D; Sosa, Julie Ann; Baloch, Zubair; Bischoff, Lindsay; Bloom, Gary; Brent, Gregory A; Brock, Pamela L; Chou, Roger; Flavell, Robert R; Goldner, Whitney; Grubbs, Elizabeth G; Haymart, Megan; Larson, Steven M; Leung, Angela M; Osborne, Joseph R; Ridge, John A; Robinson, Bruce; Steward, David L; Tufano, Ralph P; Wirth, Lori J

PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma

基于PET-CT的宿主代谢(PETMet)特征与胃食管腺癌的病理反应相关

White, Charlie; Jayaprakasam, Vetri Sudar; Tenet, Megan; Tang, Laura H; Schattner, Mark A; Janjigian, Yelena Y; Maron, Steven B; Schöder, Heiko; Larson, Steven M; Gönen, Mithat; Datta, Jashodeep; Coit, Daniel G; Mauguen, Audrey; Strong, Vivian E; Vitiello, Gerardo A

(225)Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer

(225)Ac α-预靶向放射免疫疗法治疗表达人表皮生长因子受体2的乳腺癌

Rinne, Sara S; Burnes Vargas, Daniela; Seo, Shin; Veach, Darren; McDevitt, Michael R; Vaughn, Brett A; Xu, Hong; Guo, Hong-Fen; Fung, Edward K; de Stanchina, Elisa; Miranda, Ileana C; Larson, Steven M; Cheung, Nai Kong V; Cheal, Sarah M

IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies

用于实体恶性肿瘤免疫PET的IL13Rα2靶向抗体

Gajecki, Leah; Lebedeva, Irina V; Liao, Yu-Rou; Ambriz, Daisy; Carter, Lukas M; Kumpf, Melina; Lovibond, Samantha; Hachey, Justin S; Graham, Maya S; Postow, Michael; Lewis, Jason S; Andrew, David P; Baca, Manuel; Schöder, Heiko; Larson, Steven M; Veach, Darren R; Krebs, Simone